Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results
Sanuwave (NASDAQ: SNWV) will host a live conference call on May 13, 2026 at 8:30 AM ET to present Q1 2026 financial results.
Rhea-AI Summary
Sanuwave (NASDAQ: SNWV) will host a live conference call on May 13, 2026 at 8:30 AM ET to present Q1 2026 financial results. Telephone and webcast access are provided; replay available through May 27, 2026. Materials will be posted at the company investor website.
Dial-in numbers, conference ID, webcast link, and replay details are available for investors to listen live or on replay.
Positive
- None.
Negative
- None.
Details
News Market Reaction – SNWV
On May 7, the first trading day after this news, SNWV closed 4.59% above the previous close.
Data tracked by StockTitan Argus for the May 7 session.
Key Figures
- Conference date
- May 13, 2026
- Scheduled Q1 2026 financial results call
- Conference time
- 8:30 AM (ET)
- Start time for Q1 2026 results call
- Toll-free dial-in
- 1-833-316-1983
- Participant access number for live call
- International dial-in
- 1-785-838-9310
- International participant access number
- Conference ID
- SANUWAVE
- ID required to join live conference call
- Replay end date
- May 27, 2026
- Last day replay of the call is available
- Replay toll-free
- 1-844-512-2921
- Primary replay access number
- Replay Access ID
- 11161765
- Code required to listen to conference replay
Previous Conferences,earnings Reports
-
Scheduled call to present Q4 and full-year 2025 financial results.
-
Announced Q3 2025 financial results conference call with replay details.
-
Set Q2 2025 financial results conference call and investor materials access.
-
Announced Q1 2025 results call with dial-in and replay instructions.
-
Planned call to review Q4 and full-year 2024 financial performance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDEN PRAIRIE, Minn., May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Wednesday, May 13, 2026, at 8:30 AM (ET) to present its Q1 2026 financial results.
Telephone access to the call will be available by dialing the following numbers:
Participant Dial-in Information
Toll Free: 1-833-316-1983
Toll/International: 1-785-838-9310
Conference ID: SANUWAVE
OR click the link below to access the live webcast:
https://viavid.webcasts.com/starthere.jsp?ei=1762392&tp_key=537d7338d6
Materials for the conference call will be included on the Company’s website at www.sanuwave.com/investors.
A replay will be made available through Wednesday, May 27, 2026:
Toll-Free: 1-844-512-2921 or 1-412-317-6671
Replay Access ID: 11161765
About Sanuwave
Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
Sanuwave's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations, plans for future business development activities and expectations regarding the impact of changes in tariff rates. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with regulatory oversight, the Company’s ability to manage its capital resources, competition and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.